Cite
HARVARD Citation
Coghlan, E. et al. (2017). Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma. International journal of gynecological cancer. 27 (4), pp. 708-713. [Online].